When did AngioDynamics report Q3 2025 earnings?

AngioDynamics (ANGO) reported Q3 2025 earnings on October 2, 2025 before market open.

What were AngioDynamics's Q3 2025 revenue and EPS?

AngioDynamics reported revenue of $75.7M and diluted EPS of $-0.10 for Q3 2025.

Did AngioDynamics beat estimates in Q3 2025?

Revenue missed the consensus estimate of $76.3M by $601.0K. EPS beat the consensus estimate of $-0.14 by $0.04.

How did AngioDynamics's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 12.2% from $67.5M a year earlier and diluted EPS grew 9.1% from $-0.11.

Where can I find AngioDynamics's Q3 2025 SEC filings?

You can read the 8-K earnings release (0001140361-25-037060) and the 10-Q periodic report (0001628280-25-043689) directly on SEC EDGAR. The filing index links above go to sec.gov.

AngioDynamics ANGO Q3 2025 earnings

Reported October 2, 2025 · Before market open

Revenue$75.7MMiss by $601.0K Diluted EPS-$0.10Beat by $0.04

Revenue estimate$76.3M

EPS estimate-$0.14

Next report

Jul 21, 2026 (In 4 weeks)

Revenue estimate$80.2M

EPS estimate-$0.11

Versus estimates

Revenue

Q1 2026$78.4MBeat by $1.7M Q4 2025$79.4MBeat by $3.0M

Q3 2025$75.7MMiss by $601.0K

Q2 2025$80.2MBeat by $5.9M Q1 2025$72.0MMiss by $2.3M Q4 2024$72.8MBeat by $2.3M

Diluted EPS

Q1 2026-$0.07Beat by $0.04 Q4 2025-$0.15Miss by $0.05

Q3 2025-$0.10Beat by $0.04

Q2 2025-$0.03Beat by $0.10 Q1 2025$0.03Beat by $0.16 Q4 2024-$0.04Beat by $0.07

Ask the moment AngioDynamics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did AngioDynamics report Q3 2025 earnings?: AngioDynamics (ANGO) reported Q3 2025 earnings on October 2, 2025 before market open.
What were AngioDynamics's Q3 2025 revenue and EPS?: AngioDynamics reported revenue of $75.7M and diluted EPS of $-0.10 for Q3 2025.
Did AngioDynamics beat estimates in Q3 2025?: Revenue missed the consensus estimate of $76.3M by $601.0K. EPS beat the consensus estimate of $-0.14 by $0.04.
How did AngioDynamics's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 12.2% from $67.5M a year earlier and diluted EPS grew 9.1% from $-0.11.
Where can I find AngioDynamics's Q3 2025 SEC filings?: You can read the 8-K earnings release (0001140361-25-037060) and the 10-Q periodic report (0001628280-25-043689) directly on SEC EDGAR. The filing index links above go to sec.gov.